Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.
The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.
Even if the effort goes ahead under Trump, tobacco companies like Reynolds American and Altria are almost certain ... and said Wednesday that reducing nicotine would help nearly 13 million current ...
Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal weight rating and a $54.
The newest nicotine product comes in multiple different flavors and is growing in popularity among teenagers. Zen is *** tiny pouch full of nicotine that you put inside your gums. The process is similar.
Altria just rewarded its shareholders again with a dividend. This high-yield stock has boosted its payout annually for more than 50 years.